Latest News

Exclusive Interviews

Browse by Company

  • All
  • AIkido Pharma
  • Aion Therapeutic
  • Albert Labs
  • Aleafia Health
  • Algernon Pharmaceuticals
  • Alphamind
  • Atai Life Sciences
  • Atma Journeys
  • AWAKN
  • Beckley Psytech
  • Better Plant Sciences
  • BetterLife Pharma
  • Bexson Biomedical
  • Braxia Scientific
  • Bright Minds Biosciences
  • Brightmind
  • Buzz Capital
  • CaaMTech
  • CannaGlobal Wellness
  • CB Therapeutics
  • CBDV
  • Champignon Brands
  • Clerkenwell Health
  • Compass Pathways
  • Cybin Corp
  • Delic Corp
  • Delix Therapuetics
  • DemeRx
  • Diamond Therapeutics
  • Ehave
  • Ei Foundation
  • Ei Ventures
  • Eleusian Biosciences
  • Eleusis
  • Empower Clinics
  • Entheon Biomedical
  • Entheos Foundation
  • Field Trip Health
  • Filament Health
  • Fireside Project
  • GH Research
  • GreenStar Biosciences
  • Havn Life
  • Hollister Biosciences
  • IntelGenx
  • Levitee Labs
  • Liberty Leaf
  • Lobe Sciences
  • MagicMed
  • MAPS
  • Mind Cure
  • Mindleap
  • MindMed
  • Mindset Pharma
  • Mota Ventures
  • Mycrodose Therapeutics
  • Mydecine
  • MYND Life Sciences
  • NeonMind
  • New Wave
  • NewLeaf Brands
  • Noetic Foundry
  • Nova Mentis
  • Nova Mentis Biotech
  • Novamind
  • Numinus
  • Nutritional High
  • NYU Langone Health
  • Octarine Bio
  • Optimi Health
  • Orthogonal Thinker
  • Osmond Labs
  • Osoyoos
  • Pharmadrug
  • Pharmather
  • Pilz Bioscience
  • PSFC
  • Psilera Bioscience
  • PsyBio
  • Psyched Wellness
  • Psyence Group
  • Psygen
  • PSYK
  • Pure Extracts
  • Red Light Holland
  • Reset Pharma
  • Revive Therapeutics
  • Silo Pharma
  • Silo Wellness
  • Small Pharma
  • SYNTAC Institute
  • Synthesis Institute
  • The Lundquist Institute
  • TheraPsil
  • Thoughtful Brands
  • Tryp Therapeutics
  • Unlimited Sciences
  • Usona Institute
  • Wesana Health
  • Wuhan General Group
  • Yield Growth Corp
All
  • All
  • AIkido Pharma
  • Aion Therapeutic
  • Albert Labs
  • Aleafia Health
  • Algernon Pharmaceuticals
  • Alphamind
  • Atai Life Sciences
  • Atma Journeys
  • AWAKN
  • Beckley Psytech
  • Better Plant Sciences
  • BetterLife Pharma
  • Bexson Biomedical
  • Braxia Scientific
  • Bright Minds Biosciences
  • Brightmind
  • Buzz Capital
  • CaaMTech
  • CannaGlobal Wellness
  • CB Therapeutics
  • CBDV
  • Champignon Brands
  • Clerkenwell Health
  • Compass Pathways
  • Cybin Corp
  • Delic Corp
  • Delix Therapuetics
  • DemeRx
  • Diamond Therapeutics
  • Ehave
  • Ei Foundation
  • Ei Ventures
  • Eleusian Biosciences
  • Eleusis
  • Empower Clinics
  • Entheon Biomedical
  • Entheos Foundation
  • Field Trip Health
  • Filament Health
  • Fireside Project
  • GH Research
  • GreenStar Biosciences
  • Havn Life
  • Hollister Biosciences
  • IntelGenx
  • Levitee Labs
  • Liberty Leaf
  • Lobe Sciences
  • MagicMed
  • MAPS
  • Mind Cure
  • Mindleap
  • MindMed
  • Mindset Pharma
  • Mota Ventures
  • Mycrodose Therapeutics
  • Mydecine
  • MYND Life Sciences
  • NeonMind
  • New Wave
  • NewLeaf Brands
  • Noetic Foundry
  • Nova Mentis
  • Nova Mentis Biotech
  • Novamind
  • Numinus
  • Nutritional High
  • NYU Langone Health
  • Octarine Bio
  • Optimi Health
  • Orthogonal Thinker
  • Osmond Labs
  • Osoyoos
  • Pharmadrug
  • Pharmather
  • Pilz Bioscience
  • PSFC
  • Psilera Bioscience
  • PsyBio
  • Psyched Wellness
  • Psyence Group
  • Psygen
  • PSYK
  • Pure Extracts
  • Red Light Holland
  • Reset Pharma
  • Revive Therapeutics
  • Silo Pharma
  • Silo Wellness
  • Small Pharma
  • SYNTAC Institute
  • Synthesis Institute
  • The Lundquist Institute
  • TheraPsil
  • Thoughtful Brands
  • Tryp Therapeutics
  • Unlimited Sciences
  • Usona Institute
  • Wesana Health
  • Wuhan General Group
  • Yield Growth Corp
Mydecine Press Release
Press Release

Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data

Tryp Therapeutics PR
Press Release

Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders

Bright Minds Biosciences
Press Release

Bright Minds Biosciences Provides Scientific Update

Mycrodose Therapeutics
Press Release

Mycrodose Therapeutics Successfully Completes Oversubscribed Private Placement to Expand Existing Patent Portfolio of Breakthrough Advanced Drug Delivery Technologies

Psyched Wellness Press Release
Press Release

Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1

Small Pharma PR
Press Release

Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy

ATAI Life Sciences Press Release
Press Release

DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder

Mindset Pharma Press Release
Press Release

Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and Improved Safety Profile for its 5-MeO-DMT-Inspired Drug Candidate, MSP-4018